Literature DB >> 2304046

Chlamydia trachomatis and inflammatory bowel disease--a coincidence?

R Orda1, Z Samra, Y Levy, Y Shperber, E Scapa.   

Abstract

Serological tests of 35 patients suffering from inflammatory bowel disease were compared to those of 35 healthy controls. The tests were performed using the indirect immunoperoxidase assay. Ninety-three per cent of 15 patients with Crohn's disease had IgG antibodies against Chlamydia, compared to 26% in the control group. In the 20 patients with ulcerative colitis, 45% had IgG antibodies against Chlamydia, compared to 10% in the control group. High serum titres of IgG antibodies were found in most of the patients with inflammatory bowel disease, mainly with Crohn's disease, while weak reactions appeared in most of the controls in which antibodies were detected. These results suggest a high incidence of Chlamydia infection in the studied patients with inflammatory bowel disease, especially in those with Crohn's disease. The possible association between Chlamydia trachomatis and inflammatory bowel disease is discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2304046      PMCID: PMC1292456          DOI: 10.1177/014107689008300108

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


  15 in total

1.  Positive frei tests in 7 cases of morbus Crohn (regional ileitis).

Authors:  J TOMENIUS; E LARRE; I LINDGREN; B BLUMENTHAL; G LINDEWALL
Journal:  Gastroenterologia       Date:  1963

2.  Agent transmissible from Crohn's disease tissue.

Authors:  D N Mitchell; R J Rees
Journal:  Lancet       Date:  1970-07-25       Impact factor: 79.321

3.  Pathogenetic events in intestinal chlamydial infections leading to polyarthritis in calves.

Authors:  A K Eugster; J Storz
Journal:  J Infect Dis       Date:  1971-01       Impact factor: 5.226

Review 4.  Crohn's disease. New concepts of pathogenesis and current approaches to treatment.

Authors:  S P James; W Strober; T C Quinn; S H Danovitch
Journal:  Dig Dis Sci       Date:  1987-11       Impact factor: 3.199

5.  Chlamydiae and inflammatory bowel disease.

Authors:  P R Elliott; T Forsey; S Darougar; J D Treharne; J E Lennard-Jones
Journal:  Gut       Date:  1981-01       Impact factor: 23.059

6.  Low frequency of chlamydial antibodies in patients with Crohn's disease and ulcerative colitis.

Authors:  D Taylor-Robinson; C A O'Morain; B J Thomas; A J Levi
Journal:  Lancet       Date:  1979-06-02       Impact factor: 79.321

7.  Antibodies against Chlamydia of lymphogranuloma-venereum type in Crohn's disease.

Authors:  J L Schuller; J Piket-van Ulsen; I V Veeken; M F Michel; E Stolz
Journal:  Lancet       Date:  1979-01-06       Impact factor: 79.321

8.  Chlamydia, cytomegalovirus, and Yersinia in inflammatory bowel disease.

Authors:  E T Swarbrick; J G Kingham; H L Price; A J Blackshaw; P D Griffiths; S Darougar; N A Buckell
Journal:  Lancet       Date:  1979-07-07       Impact factor: 79.321

9.  Experimental proctitis due to rectal infection with Chlamydia trachomatis in nonhuman primates.

Authors:  T C Quinn; H R Taylor; J Schachter
Journal:  J Infect Dis       Date:  1986-11       Impact factor: 5.226

10.  Agglutinins to bacteria in Crohn's disease.

Authors:  N Matthews; J F Mayberry; J Rhodes; L Neale; J Munro; F Wensinck; G H Lawson; A C Rowland; G A Berkhoff; S W Barthold
Journal:  Gut       Date:  1980-05       Impact factor: 23.059

View more
  7 in total

Review 1.  Crohn's disease and infections: a complex relationship.

Authors:  Gert De Hertogh; Karel Geboes
Journal:  MedGenMed       Date:  2004-08-10

Review 2.  Evidence for the involvement of infectious agents in the pathogenesis of Crohn's disease.

Authors:  Gert De Hertogh; Jeroen Aerssens; Karen P Geboes; Karel Geboes
Journal:  World J Gastroenterol       Date:  2008-02-14       Impact factor: 5.742

3.  NOD2 and ATG16L1 polymorphisms affect monocyte responses in Crohn's disease.

Authors:  Dylan M Glubb; Richard B Gearry; Murray L Barclay; Rebecca L Roberts; John Pearson; Jacqui I Keenan; Judy McKenzie; Robert W Bentley
Journal:  World J Gastroenterol       Date:  2011-06-21       Impact factor: 5.742

4.  Nonpathogenic Colonization with Chlamydia in the Gastrointestinal Tract as Oral Vaccination for Inducing Transmucosal Protection.

Authors:  Luying Wang; Cuiming Zhu; Tianyuan Zhang; Qi Tian; Nu Zhang; Sandra Morrison; Richard Morrison; Min Xue; Guangming Zhong
Journal:  Infect Immun       Date:  2018-01-22       Impact factor: 3.441

5.  Mucosal cell-mediated immunity to mycobacterial, enterobacterial and other microbial antigens in inflammatory bowel disease.

Authors:  J P Ibbotson; J R Lowes; H Chahal; J S Gaston; P Life; D S Kumararatne; H Sharif; J Alexander-Williams; R N Allan
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

6.  ELISA Serology for Antibodies Against Chlamydia trachomatis in Crohn's Disease.

Authors:  Herbert J Van Kruiningen; Zeinab Helal; Ariane Leroyer; Antonio Garmendia; Corrine Gower-Rousseau
Journal:  Gastroenterology Res       Date:  2018-01-03

7.  The cryptic plasmid is more important for Chlamydia muridarum to colonize the mouse gastrointestinal tract than to infect the genital tract.

Authors:  Lili Shao; Jose Melero; Nu Zhang; Bernard Arulanandam; Joel Baseman; Quanzhong Liu; Guangming Zhong
Journal:  PLoS One       Date:  2017-05-25       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.